A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice-Reference-Cited by-同舟云学术

A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice

Published:2017-03 Issue: Volume:80 Page:27-36
ISSN:0891-0618
Container-title:Journal of Chemical Neuroanatomy
language:en
Short-container-title:Journal of Chemical Neuroanatomy

Author:

Martín-Álvarez R.,Paúl-Fernández N.,Palomo V.,Gil C.,Martínez A.,Mengod G.

Funder

Instituto de Salud Carlos III

Stephen McInerney for english corrections

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience

Reference62 articles.

1. Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis;Archambault;J. Neuroimmunol.,2006

2. Apoptosis control by death and decoy receptors;Ashkenazi;Curr. Opin. Cell Biol.,1999

3. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins;Baker;Eur. J. Immunol.,1994

4. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis;Bauer;Glia,1995

5. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms;Beavo;Physiol. Rev.,1995

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agriculture and environmental management through nanotechnology: Eco-friendly nanomaterial synthesis for soil-plant systems, food safety, and sustainability;Science of The Total Environment;2024-05

2. Glycogen Synthase Kinase-3β Inhibitor VP3.15 Ameliorates Neurogenesis, Neuronal Loss and Cognitive Impairment in a Model of Germinal Matrix-intraventricular Hemorrhage of the Preterm Newborn;Translational Stroke Research;2024-01-17

3. Efficacy of a benzothiazole‐based LRRK2 inhibitor in oligodendrocyte precursor cells and in a murine model of multiple sclerosis;CNS Neuroscience & Therapeutics;2024-01

4. Phosphodiesterase 7 as a therapeutic target – Where are we now?;Cellular Signalling;2023-08

5. Neuronal activity and remyelination: new insights into the molecular mechanisms and therapeutic advancements;Frontiers in Cell and Developmental Biology;2023-07-26